Healthcare -
Biotechnology - NASDAQ - US
$ 4.16
-11.7 %
$ 86.5 M
Market Cap
-0.7
P/E
Price Target
Average
320.67%
Revenue Forecast
Estimate
73.80%
EBIT
Estimate
68.76%
Net Income
Estimate
28.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Adverum Biotechnologies, Inc.
Wall Street analysts predict an average 1-year price target for ADVM of $17.5 , with forecasts ranging from
a
low of
$10 to a high of $28 .
ADVM Lowest Price Target
Wall Street Target
10 USD
140.38%
ADVM Average Price Target
Wall Street Target
17.5 USD
320.67%
ADVM Highest Price Target
Wall Street Target
28 USD
573.08%
REVENUE FORECAST
Revenue Forecast Chart ADVM
EBIT FORECAST
EBIT Forecast Chart ADVM
NET INCOME FORECAST
Net Income Chart ADVM